Iftikhar O Ebrahim
Iftikhar O Ebrahim publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Atrial Fibrillation Management and Outcomes.
- World rank
- #1,166,305 of 7,710,434 ranked researchers
- Rank in South Africa
- #4,730 of 29,826
- Works
- 23
- Citations
- 1.1k
- Citations per work
- 48.7
What does Iftikhar O Ebrahim research?
Iftikhar O Ebrahim's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1566.7%
- Medicine1566.7%
- Everything else730.1%
- Life Sciences13.2%
- 1Cardiology and Cardiovascular Medicine25% of their works
- 2Surgery22% of their works
- 3Endocrinology, Diabetes and Metabolism11% of their works
- 4Epidemiology5% of their works
- 5Cancer Research3% of their works
- 6Hepatology3% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Diabetes Treatment and Management
- Protease and Inhibitor Mechanisms
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
Which keywords describe Iftikhar O Ebrahim's research?
The keywords of their largest research topics: Cholesterol-lowering, Heart Failure, Statins, Cardiovascular Disease, Obesity, Clinical Guidelines, Echocardiography and Diabetes.
- Matrix Metalloproteinases
- Diastolic Function
- Blood Pressure
- Implantable Cardioverter-Defibrillator
- Cardiac Resynchronization Therapy
- Anticoagulant Therapy
- Diabetes
- Clinical Guidelines
- Cardiovascular Disease
- Heart Failure
- Cholesterol-lowering
- Statins
- Obesity
- Echocardiography
- Metabolic Syndrome
- Atrial Fibrillation
- Cardiovascular Outcomes
- Type 2 Diabetes
- Chamber Quantification
- Hypertension
- Tissue Inhibitors of Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cholesterol-lowering81 topic
- Heart Failure83 topics
- Statins81 topic
- Cardiovascular Disease62 topics
- Obesity62 topics
- Clinical Guidelines52 topics
- Echocardiography52 topics
- Diabetes41 topic
- Metabolic Syndrome41 topic
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Cardiac Resynchronization Therapy31 topic
- Cardiovascular Outcomes31 topic
- Implantable Cardioverter-Defibrillator31 topic
- Type 2 Diabetes31 topic
- Blood Pressure21 topic
- Chamber Quantification21 topic
- Diastolic Function21 topic
- Hypertension21 topic
- Matrix Metalloproteinases21 topic
- Tissue Inhibitors of Metalloproteinases21 topic
Where does Iftikhar O Ebrahim work?
Iftikhar O Ebrahim's main affiliation in the publication record is Netcare Unitas Hospital, South Africa.
How many publications and citations does Iftikhar O Ebrahim have?
OpenAlex counts 23 works and 1,121 citations for Iftikhar O Ebrahim, an h-index of 11, ranking #1,166,305 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Iftikhar O Ebrahim. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.